Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
about
Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis.On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis COccurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection.Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.Drug Treatment for Chronic Hepatitis C Infection and Cancer RiskCon: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma.OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.Regulation of the Interferon Response by lncRNAs in HCV Infection.
P2860
Q33745372-2B63A253-7758-41AB-BACF-1D479D69CAFFQ33803540-F42CD039-07B8-4551-8800-2D363BADBF97Q40059588-C759BE15-10F5-4EA0-9FBA-08017154F0C4Q41924669-98C75831-ABBB-4020-BFC8-7FD116A9425BQ41934445-37AA3ECF-1E98-4CDF-9B48-99212AFC1CC2Q45326436-02198AF1-10B3-42F8-8464-A5FF01359D5CQ47628251-8FA90F14-43A8-4C91-B7C4-D60A840D8B7AQ47657221-DCCAC337-7ED1-487B-94F9-1650DD3E6254Q54239042-0890F996-C989-433E-B7F2-E17A480EEDACQ54243868-B0E9AEAA-D91E-44CF-89EE-833060BAF936Q55122208-91B6FF6F-A023-4EF2-A47D-F257852140C9
P2860
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Hepatocellular carcinoma decre ...... with direct-acting antivirals.
@en
type
label
Hepatocellular carcinoma decre ...... with direct-acting antivirals.
@en
prefLabel
Hepatocellular carcinoma decre ...... with direct-acting antivirals.
@en
P2093
P2860
P1476
Hepatocellular carcinoma decre ...... with direct-acting antivirals.
@en
P2093
Laura Kulik
Robert J Lewandowski
Stacey B Prenner
Steven L Flamm
P2860
P304
P356
10.1016/J.JHEP.2017.01.020
P577
2017-02-02T00:00:00Z